Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KARS1 | Q15046 | 13/20 | 0.51 |
| ▸ | WNT3A | P56704 | 2/20 | 0.39 |
| ▸ | CDK9 | P50750 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.33 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1755672 | 0.93 | KARS1 (0.49) | KARS1WNT3ACDK9MEN1KMT2A | |
| SCHEMBL1704220 | 0.83 | KARS1 (0.74) | KARS1PRKD1PRKD2 | |
| SCHEMBL901298 | 0.78 | KARS1 (0.64) | KARS1KMT2APRKD1 | |
| SCHEMBL902876 | 0.75 | KARS1 (0.43) | KARS1WNT3A | |
| SCHEMBL902874 | 0.75 | KARS1 (0.43) | KARS1WNT3A | |
| SCHEMBL1704577 | 0.75 | KARS1 (0.56) | KARS1WNT3A | |
| SCHEMBL901535 | 0.74 | KARS1 (0.58) | KARS1 | |
| SCHEMBL901423 | 0.73 | KARS1 (0.71) | KARS1PRKD1PRKD2 | |
| SCHEMBL1704682 | 0.73 | KARS1 (0.71) | KARS1PRKD1PRKD2 | |
| SCHEMBL1755681 | 0.73 | KARS1 (0.56) | KARS1PRKD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2441755-A1 | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors | Almirall, S.A. (ES) | 2012-04-18 | — | — | EP | claimed |
| EP-2441755-A1 | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors | Almirall, S.A. (ES) | 2012-04-18 | — | — | EP | disclosed |